Clinical Trial Update: TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) [Phase 2]

View source ↗

Summary

Phase 2 trial update for TAS-102 (Lonsurf) in metastatic or locally advanced unresectable pancreatic adenocarcinoma after first-line therapy; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: University of Florida | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-02-04